Hepatitis Monthly

Published by: Kowsar

Tehran Hepatitis Conference: An International Meeting with the Goal of Middle East without Viral Hepatitis

Meisam Fathi 1 , 2 , Mohammad Saeid Rezaee-Zavareh 1 , 2 , 3 , * , Heidar Sharafi 1 , 2 , Khashayar Hesamizadeh 1 , 2 , Hamidreza Karimi-Sari 1 , 2 , 3 , Seyed Moayed Alavian 1 , 2 and Javad Karimi 1 , 2
Authors Information
1 Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Middle East Liver Diseases (MELD) Center, Tehran, IR Iran
3 Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
Article information
  • Hepatitis Monthly: November 01, 2016, 16 (11); e40539
  • Published Online: October 19, 2016
  • Article Type: Meeting Report
  • Received: July 2, 2016
  • Revised: September 4, 2016
  • Accepted: October 10, 2016
  • DOI: 10.5812/hepatmon.40539

To Cite: Fathi M, Saeid Rezaee-Zavareh M, Sharafi H, Hesamizadeh K, Karimi-Sari H, et al. Tehran Hepatitis Conference: An International Meeting with the Goal of Middle East without Viral Hepatitis, Hepat Mon. 2016 ;16(11):e40539. doi: 10.5812/hepatmon.40539.

Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Middle East and Viral Hepatitis
2. Report of Sixth Tehran Hepatitis Conference, Using of a Computerized System For Better Holding of it
3. Seventh Tehran Hepatitis Conference
4. Conflict of Interest
References
  • 1. 2016;
  • 2. Qirbi N, Hall AJ. Epidemiology of hepatitis B virus infection in the Middle East. Eastern Mediterranean Health J. 2001; 7(6): 1034-45
  • 3. Specialist Panel on Chronic Hepatitis BTME. A review of chronic hepatitis B epidemiology and management issues in selected countries in the Middle East. J Viral Hepat. 2012; 19(1): 9-22[DOI][PubMed]
  • 4. Frank C, Mohamed MK, Strickland G, Lavanchy D, Arthur RR, Magder LS, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. The Lancet. 2000; 355(9207): 887-91
  • 5. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013; 57(4): 1333-42[DOI][PubMed]
  • 6. Hesamizadeh K, Sharafi H, Rezaee-Zavareh M, Behnava B, Alavian SM. Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals. Hepatmon. 2016; 16(4)
  • 7. Rezaee-Zavareh MS, Sa'adat SH, Alavian SM. Hepatitis Monthly, an International Journal in the Field of Hepatology. Hepat Mon. 2016; 16(3): 37015[DOI][PubMed]
  • 8. Alavian SM, Rezaee-Zavareh MS. The Middle East and hepatitis C virus infection: does it need special attention? Lancet Infect Dis. 2016; 16(9): 1006-7[DOI][PubMed]
  • 9. Rizzetto M, Canese MG, Arico S, Crivelli O, Trepo C, Bonino F, et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977; 18(12): 997-1003[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments